Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

AbstractAbout

  Head and Neck Cancer

  Free Subscription


16.03.2026

1 Am J Pathol
1 Am J Surg
1 Ann Otol Rhinol Laryngol
2 Ann Surg
1 Ann Thorac Surg
1 Anticancer Res
3 BMC Cancer
1 Br J Cancer
1 Br J Oral Maxillofac Surg
3 Cancer
5 Clin Cancer Res
1 Clin Nucl Med
5 Dis Esophagus
1 Gastrointest Endosc
17 Head Neck
5 Hum Pathol
2 Int J Cancer
4 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
1 J Laryngol Otol
2 J Nucl Med
1 J Oral Maxillofac Surg
1 Laryngoscope
5 Ophthalmic Plast Reconstr Surg
12 Oral Oncol
2 Otolaryngol Head Neck Surg
3 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiol Artif Intell
1 Radiol Imaging Cancer
1 Radiologia (Engl Ed)
13 Radiother Oncol
13 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Pathol

  1. TORIGOE R, Koma YI, Nomura N, Yokoo H, et al
    Bone Marrow Stromal Cell Antigen 2 Promotes Esophageal Squamous Cell Carcinoma Progression by Mediating the Cell-Cell Interaction between Cancer Cells and Cancer-Associated Fibroblasts.
    Am J Pathol. 2026 Feb 26:S0002-9440(26)00039.
    PubMed         Abstract available


    Am J Surg

  2. MILAN M, Thomas SM, Lindsay CV, Frieze TW, et al
    Data-driven thresholds for tumor size and nodal involvement in oncocytic thyroid carcinoma: A population-based analysis.
    Am J Surg. 2026;255:116874.
    PubMed         Abstract available


    Ann Otol Rhinol Laryngol

  3. BERLUCCHI M, Comincini I, Redaelli de Zinis LO, Ghini I, et al
    Pediatric Benign Nasal Triton Tumor: Its Diagnosis and Treatment.
    Ann Otol Rhinol Laryngol. 2026;135:313-318.
    PubMed         Abstract available


    Ann Surg

  4. LUKETICH JD, Sarkaria ID, Levy RM, Alicuben ET, et al
    A Phase III Randomized Controlled Trial of Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Minimally Invasive Esophagectomy or Robot-assisted Minimally Invasive Esophagectomy.
    Ann Surg. 2026;283:569-580.
    PubMed         Abstract available

  5. BOOKA E, Kato K, Ito Y, Daiko H, et al
    Prognostic Impact of Postoperative Complications After Neoadjuvant Therapy Followed by Esophagectomy for Esophageal Cancer: An Exploratory Analysis of Phase III Trial JCOG1109.
    Ann Surg. 2026 Mar 6. doi: 10.1097/SLA.0000000000007045.
    PubMed         Abstract available


    Ann Thorac Surg

  6. ABOU CHAAR MK, Godin A, Harmsen WS, Wzientek C, et al
    Determinants of Long-term Survival Decades After Esophagectomy for Esophageal Cancer.
    Ann Thorac Surg. 2023;116:1036-1044.
    PubMed         Abstract available


    Anticancer Res

  7. UEDA Y, Okada T, Okamoto I, Fushimi C, et al
    Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS Status.
    Anticancer Res. 2026;46:1639-1650.
    PubMed         Abstract available


    BMC Cancer

  8. TANG P, Gao L, Zuo S, Zhang K, et al
    Adebrelimab plus chemotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC): a single-center, phase II, single-arm, open-label clinical trial (ADENEO) protocol.
    BMC Cancer. 2026 Mar 13. doi: 10.1186/s12885-026-15850.
    PubMed        

  9. AGATE S, Patil S, Sarade M, Lokhande D, et al
    Overall survival of oral cancer from the population-based cancer registries of the Konkan area, Maharashtra, India.
    BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15689.
    PubMed        

  10. ZHOU G, Sijtsema NM, Li Y, Zhai T, et al
    Prediction of treatment outcome in nasopharyngeal carcinoma patients.
    BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15570.
    PubMed        


    Br J Cancer

  11. HOSE L, Tekin AC, Verwaaijen B, Kim R, et al
    Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC.
    Br J Cancer. 2026;134:961-974.
    PubMed         Abstract available


    Br J Oral Maxillofac Surg

  12. SIMPSON CD, Turner TP, Dickson KS, Taylor S, et al
    Accuracy of the Head and Neck Cancer Risk Calculator in oral and maxillofacial surgery.
    Br J Oral Maxillofac Surg. 2026 Feb 18:S0266-4356(26)00036.
    PubMed         Abstract available


    Cancer

  13. BHATIA A, Chen Z, Zhang Y, Bruce JY, et al
    A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).
    Cancer. 2026;132:e70346.
    PubMed         Abstract available

  14. KACHNIC LA, Moughan J, Hong TS, Haddock MG, et al
    Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma.
    Cancer. 2026;132:e70345.
    PubMed         Abstract available

  15. PATEL SA, Gibson MK, Deal A, Sheth S, et al
    A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.
    Cancer. 2023;129:3381-3389.
    PubMed         Abstract available


    Clin Cancer Res

  16. CHI Y, Zheng X, Zhang Y, Shi F, et al
    Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase â…¡ Trial.
    Clin Cancer Res. 2023 Aug 18:CCR-22-3406. doi: 10.1158/1078-0432.CCR-22-3406.
    PubMed         Abstract available

  17. BEYAERT SP, Loriot AE, Huyghe ND, Goebbels RM, et al
    Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111-24111).
    Clin Cancer Res. 2023;29:4076-4087.
    PubMed         Abstract available

  18. DAI Y, Wang Z, Xia Y, Li J, et al
    Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities.
    Clin Cancer Res. 2023;29:2845-2858.
    PubMed         Abstract available

  19. YANG Y, Yan X, Jiang H, Kang M, et al
    PET/CT-Guided Neoadjuvant Tislelizumab Plus Chemotherapy/Chemoradiotherapy for Resectable Esophageal Squamous Cell Carcinoma: RATIONALE-213 Final Analysis.
    Clin Cancer Res. 2026 Mar 2. doi: 10.1158/1078-0432.CCR-25-2367.
    PubMed         Abstract available

  20. YIN S, Cheng L, Hu E, Li J, et al
    Association of Intratumoral Microbiota with Prognosis in Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2026 Feb 27. doi: 10.1158/1078-0432.CCR-25-4420.
    PubMed         Abstract available


    Clin Nucl Med

  21. HE J, He L, Deng Y, Zhang W, et al
    Incidental Uptake of 18F-AlF-NOTA-pentixather PET/CT in Anaplastic Thyroid Carcinoma.
    Clin Nucl Med. 2026 Mar 3. doi: 10.1097/RLU.0000000000006382.
    PubMed         Abstract available


    Dis Esophagus

  22. PROVOOST N, Zellenrath PA, Plompen EPC, Oudijk L, et al
    Lessons learned: the importance of timely recognition of verrucous squamous cell carcinoma in the esophagus.
    Dis Esophagus. 2026;39:doag021.
    PubMed         Abstract available

  23. KOHN GP, Litle V, Eliya Y, Leng S, et al
    ISDE guidelines on the management of cT2N0 esophageal cancer.
    Dis Esophagus. 2026;39:doag019.
    PubMed         Abstract available

  24. GARBARINO GM, Pansa A, Giorgi L, De Martino R, et al
    Balancing innovation and risks in esophageal surgery: lessons from the hybrid Ivor-Lewis technique.
    Dis Esophagus. 2026;39:doag020.
    PubMed         Abstract available

  25. ABDEL FATTAH AR, Mahdy K, Abdelhamid A, Nanthakumaran S, et al
    Prognostic factors for paraconduit hernia in adult patients post-esophagectomy for cancer: a systematic review.
    Dis Esophagus. 2026;39:doag017.
    PubMed         Abstract available

  26. ENKE T, Pokala SK, Hensen C, Brennan C, et al
    Recurrent Barrett's esophagus-related neoplasia is uncommon after successful endoscopic eradication therapy over long-term follow-up.
    Dis Esophagus. 2026;39:doag018.
    PubMed         Abstract available


    Gastrointest Endosc

  27. KAHN A, Song K, Dhaliwal L, Thanawala S, et al
    Long-term outcomes following successful endoscopic treatment of T1 esophageal adenocarcinoma: a multicenter cohort study.
    Gastrointest Endosc. 2023;98:713-721.
    PubMed         Abstract available


    Head Neck

  28. CIRELLI MA JR, Hintze JM, Cave TB, ALNafisee D, et al
    Medial Sural Artery Perforator Flap Radiographic Vascular Characteristics.
    Head Neck. 2026;48:1097-1103.
    PubMed         Abstract available

  29. HALLE TR, Cao AC, Naik AG, Weinstein GS, et al
    Risk of Occult Contralateral Neck Metastasis in Early-Stage HPV-Related Lateralized Cancer of the Base of the Tongue.
    Head Neck. 2026;48:986-993.
    PubMed         Abstract available

  30. YE Z, Yan H, Li X, Yang D, et al
    Radiotherapy Outcomes and Prognostic Factors in Head and Neck NUT Carcinoma: A Single-Center Cohort Analysis.
    Head Neck. 2026;48:975-985.
    PubMed         Abstract available

  31. KOIZUMI K, Obayashi F, Higaki M, Morishita K, et al
    Postoperative Adjuvant Therapy in Resectable Advanced Oral Squamous Cell Carcinoma With Intermediate Risk Factors.
    Head Neck. 2026;48:1069-1076.
    PubMed         Abstract available

  32. YAO C, Cao D, Feng Y, Ding Y, et al
    Sclerotic Head and Neck Paragangliomas: An Unfavorable Indicator Associated With Surgical Outcomes.
    Head Neck. 2026;48:925-931.
    PubMed         Abstract available

  33. MARZI MANFRONI A, Scaccini OP, Ceccariglia F, Querzoli G, et al
    Computer-Assisted Versus Freehand Surgery in Oncological Margins Control for Oral Squamous Cell Carcinomas: A Retrospective Case-Control Clinical Study.
    Head Neck. 2026;48:1003-1015.
    PubMed         Abstract available

  34. XUE E, Adeyelu T, Krause H, Elliott A, et al
    Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma.
    Head Neck. 2026;48:932-940.
    PubMed         Abstract available

  35. SANTIVANEZ JJ, Escallon A, Vasconez J, Gonzalez Devia D, et al
    Correlation Between (18)F-Choline PET/CT and Surgical Outcomes in Primary Hyperparathyroidism With Negative or Inconclusive Imaging: A Retrospective Cohort of 70 Cases.
    Head Neck. 2026;48:960-966.
    PubMed         Abstract available

  36. SAYEED S, Stanisce L, Ramirez RJ, Sohn SY, et al
    An Isolated Soft Tissue Ectopic Paraganglioma in the Head and Neck.
    Head Neck. 2026;48:E40-E45.
    PubMed         Abstract available

  37. SAUTER C, Erhart P, Bockler D, Schuler P, et al
    Quality of Life After Surgical Treatment of Head and Neck Paragangliomas.
    Head Neck. 2026;48:941-949.
    PubMed         Abstract available

  38. CHELVARAJAH RC, Chee LYS, Su J, O'Sullivan B, et al
    Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.
    Head Neck. 2026 Mar 12. doi: 10.1002/hed.70230.
    PubMed         Abstract available

  39. YAO CMKL, Beatty S, Yan F, Esemezie AO, et al
    Practices and Impressions of Head and Neck Cancer Multidisciplinary Tumor Boards Findings From an American Head and Neck Society Survey.
    Head Neck. 2026 Mar 11. doi: 10.1002/hed.70228.
    PubMed         Abstract available

  40. CHEN Y, Hong Y, Zhang Y, Guan H, et al
    Assessment Tools of Radiation Skin Injury in Head and Neck Cancer: A Narrative Review of Preclinical and Clinical Studies.
    Head Neck. 2026 Mar 11. doi: 10.1002/hed.70229.
    PubMed         Abstract available

  41. DEAMOND H, Devault-Tousignant C, Lang J, Lo C, et al
    Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of Life.
    Head Neck. 2026 Mar 11. doi: 10.1002/hed.70231.
    PubMed         Abstract available

  42. MARRE P, Fermi M, Esposti AD, Haddad R, et al
    An International Retrospective Study Comparing Chemoradiotherapy and Primary Surgery for T3 Laryngeal Cancers.
    Head Neck. 2026 Mar 7. doi: 10.1002/hed.70225.
    PubMed         Abstract available

  43. LV G, Ji X, Zhao Q, Ding C, et al
    Thyroid Lobectomy for Unilateral Papillary Thyroid Carcinoma Patients With High-Volume (n >/= 5) Central Lymph Node Metastases.
    Head Neck. 2026 Mar 6. doi: 10.1002/hed.70217.
    PubMed         Abstract available

  44. MASSONET H, Goeleven A, Nuyts S, Vergauwen A, et al
    Dysphagia Rehabilitation Outcomes in Head and Neck Cancer Patients With Radiation Associated Dysphagia: Does Time Since (Chemo)radiation Matter?
    Head Neck. 2026 Mar 5. doi: 10.1002/hed.70207.
    PubMed         Abstract available


    Hum Pathol

  45. ERICKSON LA, Gupta S, Whaley RD, Tekin B, et al
    Selected updates in thyroid, parathyroid, and adrenal gland pathology.
    Hum Pathol. 2026;169:106029.
    PubMed         Abstract available

  46. SIAW J, Fielder T, Senff S, Palme CE, et al
    Making routine head and neck pathology Easy: From dissection to diagnosis.
    Hum Pathol. 2026;169:106030.
    PubMed         Abstract available

  47. ORTIZ REQUENA D, Montgomery EA
    What's new in upper gastrointestinal pathology: Key updates and evolving challenges in 2026.
    Hum Pathol. 2026;169:106025.
    PubMed         Abstract available

  48. ZHANG Q, Urtueta BP, Merenda E, Rotondaro G, et al
    Practical and challenging issue in thyroid cytopathology.
    Hum Pathol. 2026;169:106019.
    PubMed         Abstract available

  49. SPEAKMAN GC, Wakely PE Jr, Argyris PP
    HPV-related multiphenotypic sinonasal carcinoma: Clinicopathologic and immunohistochemical characterization of 3 cases with comprehensive literature review and emphasis on differential diagnosis.
    Hum Pathol. 2026;170:105961.
    PubMed         Abstract available


    Int J Cancer

  50. WEI C, Wei H, Chen X, Zheng Z, et al
    Patterns of recurrence after curative resection and adjuvant chemotherapy in gastric and gastroesophageal junction cancer.
    Int J Cancer. 2026;158:2240-2252.
    PubMed         Abstract available

  51. TSEGAYE AT, Mashele SA, Shing JZ, Mwansa-Kambafwile J, et al
    Race-specific temporal trends of HPV-related cancers in South Africa: An analysis of the South African National Cancer Registry, 2011-2022.
    Int J Cancer. 2025 Dec 31. doi: 10.1002/ijc.70323.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  52. YANG Y, Feng T, Fan X, Wang C, et al
    Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023;117:979-993.
    PubMed         Abstract available

  53. KIM K, Ahn YC, Oh D, Noh JM, et al
    Can Definitive Radiation Therapy Substitute Surgical Resection in Locally Advanced T3 or T4 Sinonasal Squamous Cell Carcinoma?
    Int J Radiat Oncol Biol Phys. 2023;117:893-902.
    PubMed         Abstract available

  54. HENG J, Li Z, Liu L, Zheng Z, et al
    Acetyl-CoA Acetyltransferase 2 Confers Radioresistance by Inhibiting Ferroptosis in Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023;117:966-978.
    PubMed         Abstract available

  55. GAO T, Yang Y, Zhang Z, Yang Y, et al
    A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial.
    Int J Radiat Oncol Biol Phys. 2023;117:809-820.
    PubMed         Abstract available


    J Clin Oncol

  56. LICITRA L, Tahara M, Harrington K, Olivera Hurtado de Mendoza M, et al
    Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study.
    J Clin Oncol. 2026 Mar 12:JCO2500570. doi: 10.1200/JCO-25-00570.
    PubMed         Abstract available

  57. HUANG SW, Liang YL, Tao YL, Li WF, et al
    Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials.
    J Clin Oncol. 2026 Mar 6:JCO2502111. doi: 10.1200/JCO-25-02111.
    PubMed         Abstract available


    J Laryngol Otol

  58. MCNIVEN ND, Butler J, Anari S
    Contour improvements in skin graft reconstruction of nasal defects.
    J Laryngol Otol. 2025 Dec 17:1-17. doi: 10.1017/S0022215125104040.
    PubMed        


    J Nucl Med

  59. LI A, Sultan D, Heo GS, Detering L, et al
    Assessment of CCR2 PET as a Biomarker for Head and Neck Squamous Cell Carcinoma.
    J Nucl Med. 2026 Mar 12:jnumed.125.271601. doi: 10.2967/jnumed.125.271601.
    PubMed         Abstract available

  60. HOBART J, Da Pieve C, Raes F, Borys D, et al
    PD-L1 Immuno-PET Reveals Systemic Effects of Localized Oncolytic Virotherapy in a Mouse Model of Head and Neck Cancer.
    J Nucl Med. 2026 Mar 12:jnumed.125.270922. doi: 10.2967/jnumed.125.270922.
    PubMed         Abstract available


    J Oral Maxillofac Surg

  61. JIA X, Wang X, Liu F, Sun C, et al
    New In-Continuity Neck Dissection Technique for Locally Advanced Oral Squamous Cell Carcinoma: A Retrospective Case Series.
    J Oral Maxillofac Surg. 2026 Feb 11:S0278-2391(26)00124.
    PubMed         Abstract available


    Laryngoscope

  62. MANDAVA S, Shuman AG
    The Evolution in Medical Assistance in Dying for Head and Neck Cancer.
    Laryngoscope. 2026 Mar 12. doi: 10.1002/lary.70499.
    PubMed        


    Ophthalmic Plast Reconstr Surg

  63. CORCORAN RUIZ KM, Shoshany C, Valdes Morales KL, Frankel D, et al
    Association Between Area Deprivation Index and Periocular Basal Cell Carcinoma Treated With Mohs Micrographic Surgery.
    Ophthalmic Plast Reconstr Surg. 2026;42:218-221.
    PubMed         Abstract available

  64. KARA M
    A Novel Technique in One-Staged Reconstruction of Large Lower Eyelid Defects: Orbicularis Oculi Myoperiosteal Flap.
    Ophthalmic Plast Reconstr Surg. 2025 Sep 11. doi: 10.1097/IOP.0000000000003019.
    PubMed         Abstract available

  65. DALLALZADEH LO, Bennett AL, Kislevitz M, Tenzel PA, et al
    Periocular Reconstruction Utilizing the Integra Dermal Regeneration Template.
    Ophthalmic Plast Reconstr Surg. 2026;42:168-171.
    PubMed         Abstract available

  66. WALSH KL, Whitehead K, McCartney MH, Quagliotto G, et al
    Nonneural Granular Cell Tumor of the Eyelid in a 10-Year-Old Boy.
    Ophthalmic Plast Reconstr Surg. 2025 Aug 15. doi: 10.1097/IOP.0000000000003008.
    PubMed         Abstract available

  67. DEVARAPALLI N, Teo M, Ardakani NM, DeSousa JL, et al
    Pigmented Epithelioid Melanocytoma of the Eyelid: A Case Report.
    Ophthalmic Plast Reconstr Surg. 2025 Jul 3. doi: 10.1097/IOP.0000000000003002.
    PubMed         Abstract available


    Oral Oncol

  68. PARK H, Kim BR, Yoo JH, Kim SW, et al
    Clinical implication of the 2025 ATA risk stratification in follicular thyroid carcinoma: A comparison with the 2015 ATA risk stratification.
    Oral Oncol. 2026;175:107912.
    PubMed         Abstract available

  69. MANFUSO A, Cirignaco G, Cocis S, Volpe F, et al
    Selective tracheostomy in oral cancer reconstruction with myomucosal flaps: Outcomes and an appraisal of published risk scores.
    Oral Oncol. 2026;175:107916.
    PubMed         Abstract available

  70. HUANG YJ, Fang KC, Tsai MH, Chuang HC, et al
    Swallowing-related outcomes and organ-at-risk dosimetry after proton versus photon radiotherapy in nasopharyngeal carcinoma.
    Oral Oncol. 2026;175:107906.
    PubMed         Abstract available

  71. MENG L, Wen W
    Spatial transcriptomics and single-cell analysis reveal GSTO2-mediated protective networks in oral squamous cell carcinoma tumor microenvironment.
    Oral Oncol. 2026;175:107918.
    PubMed         Abstract available

  72. NGO DQ, Le DT, Ngo QX, Le QV, et al
    Surgical outcomes of modified versus conventional transoral endoscopic thyroidectomy vestibular approach for papillary thyroid carcinoma.
    Oral Oncol. 2026;175:107908.
    PubMed         Abstract available

  73. LIU H, Wu J, Wang Y, Song S, et al
    Disease control with disitamab vedotin in HER2-low polymorphous adenocarcinoma of the tongue base after chemotherapy failure: A case report.
    Oral Oncol. 2026;175:107910.
    PubMed         Abstract available

  74. USECHE M, Norouzi A, Liao JJ, Panjwani N, et al
    Treatment of early-stage oral cavity squamous cell carcinoma at low-volume facilities impacts surgical margins and survival: an analysis of 22,258 patients from the NCDB.
    Oral Oncol. 2026;175:107901.
    PubMed         Abstract available

  75. CRACCHIOLO JR, Kavanagh F, Starc MT, Scholfield D, et al
    Defining response-adapted surgery after neoadjuvant systemic therapy in sinonasal squamous cell carcinoma.
    Oral Oncol. 2026;175:107882.
    PubMed         Abstract available

  76. MORTENSEN L, Dwyer A, Palatnik B, Wuertz BR, et al
    A novel method using electronic health record coding to generate a unique, multipurpose database for aerodigestive malignancy surveillance.
    Oral Oncol. 2026;175:107886.
    PubMed         Abstract available

  77. JAGADEESHA S, Lamenza F, Upadhaya P, Chung C, et al
    Sex-based immune differences influence tumor progression in head and neck squamous cell carcinoma.
    Oral Oncol. 2026;176:107929.
    PubMed         Abstract available

  78. DOU K, Liu D, Shi Y, Qin H, et al
    Can the submandibular gland be preserved during neck dissection in patients with oral squamous cell carcinoma?A systematic review and meta-analysis.
    Oral Oncol. 2026;176:107913.
    PubMed         Abstract available

  79. DAI WF, Nguyen L, Liu N, Chan KK, et al
    Corrigendum to "Real-world effectiveness and healthcare utilization of nivolumab for advanced head and neck cancer: A real-world population-based descriptive study" [Oral Oncol. 173 (2026) 107851].
    Oral Oncol. 2026 Mar 5:107919. doi: 10.1016/j.oraloncology.2026.107919.
    PubMed        


    Otolaryngol Head Neck Surg

  80. HSIA B, Dongre R, Veluvolu VD, Kuzniar J, et al
    Genomic Characterization of Oncocytic Carcinoma of the Thyroid Using a Large Multi-Institutional Database.
    Otolaryngol Head Neck Surg. 2026;174:696-704.
    PubMed         Abstract available

  81. CHAU IJ, Kim CH, Nguyen SA, McCray LR, et al
    Classification of Salivary Gland Tumors on Ultrasound Using Artificial Intelligence: A Systematic Review and Meta-Analysis.
    Otolaryngol Head Neck Surg. 2026;174:601-612.
    PubMed         Abstract available


    PLoS One

  82. MIZUSAWA H, Noguchi M, Tamura T, Shiraishi M, et al
    Preoperative expiratory muscle training for swallowing function in patients with esophageal cancer undergoing esophagectomy: A randomized controlled phase II trial protocol.
    PLoS One. 2026;21:e0344456.
    PubMed         Abstract available

  83. GHOZLAN H, Al-Malahmeh S, Al-Shboul O, Mistareehi AJ, et al
    Context-dependent dysregulation of store-operated calcium channels in head and neck squamous cell carcinoma.
    PLoS One. 2026;21:e0344393.
    PubMed         Abstract available

  84. NAKAMURA T, Shibata T, Ito KI
    EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells.
    PLoS One. 2026;21:e0344276.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  85. KHALIL MI, Wang J, Vu L, Yang C, et al
    The membrane-associated ubiquitin ligase MARCHF8 degrades MHC-I in HPV-positive head and neck cancer for immune evasion.
    Proc Natl Acad Sci U S A. 2026;123:e2525730123.
    PubMed         Abstract available


    Radiol Artif Intell

  86. LI Z, Yan Y, Li X, Wu K, et al
    Interpretable Machine Learning Model Using Digitized US Features for Classifying Complex Thyroid Nodules.
    Radiol Artif Intell. 2026;8:e250383.
    PubMed         Abstract available


    Radiol Imaging Cancer

  87. BASHA MAA, Almalki YE
    (68)Ga-FAPI PET/CT in Nasopharyngeal Carcinoma: A Paradigm Shift in Imaging or Just Another Tool?
    Radiol Imaging Cancer. 2026;8:e260067.
    PubMed        


    Radiologia (Engl Ed)

  88. VAZQUEZ MENDEZ E, Delgado Alvarez I, Sanchez-Montanez Garcia-Carpintero A, Escudero Fernandez JM, et al
    Fetal magnetic resonance imaging in head and neck pathology.
    Radiologia (Engl Ed). 2026;68:501697.
    PubMed         Abstract available


    Radiother Oncol

  89. HUANG Z, Qi WX, Li S, Li H, et al
    Association between radiation dose to pulmonary vein substructures and post-treatment atrial fibrillation following neoadjuvant chemoradiotherapy for esophageal squamous cell cancer.
    Radiother Oncol. 2026;217:111436.
    PubMed         Abstract available

  90. PODOBNIK G, Ibragimov B, Peterlin P, Strojan P, et al
    Dosimetric assessment of deep learning based organ-at-risk segmentation: insights from the HaN-Seg challenge.
    Radiother Oncol. 2026;217:111387.
    PubMed         Abstract available

  91. BUSATO F, Fiorentin D, Bettinelli A, Anile G, et al
    Dosiomic-based prediction of dysgeusia in head & neck cancer patients treated with radiotherapy.
    Radiother Oncol. 2023;188:109896.
    PubMed         Abstract available

  92. HE S, He D, Li J, Yu H, et al
    The role of postoperative radiotherapy (PORT) in lymphoepithelial carcinoma of the salivary gland (LECSG) and the effect of postoperative EBV DNA on prognosis.
    Radiother Oncol. 2023;188:109893.
    PubMed         Abstract available

  93. HSIEH RC, Chou YC, Hung CY, Lee LY, et al
    A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy.
    Radiother Oncol. 2023;188:109891.
    PubMed         Abstract available

  94. LIU Y, Yang B, Chen X, Zhu J, et al
    Efficient segmentation using domain adaptation for MRI-guided and CBCT-guided online adaptive radiotherapy.
    Radiother Oncol. 2023;188:109871.
    PubMed         Abstract available

  95. COSTEA M, Zlate A, Serre AA, Racadot S, et al
    Evaluation of different algorithms for automatic segmentation of head-and-neck lymph nodes on CT images.
    Radiother Oncol. 2023;188:109870.
    PubMed         Abstract available

  96. DING X, Cui X, Cui X, Wang S, et al
    Efficacy and toxicities of elective upper-neck irradiation versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: A meta-analysis.
    Radiother Oncol. 2023;188:109860.
    PubMed         Abstract available

  97. NG WEI SIANG K, Both S, Oldehinkel E, Langendijk JA, et al
    Assessment of residual geometrical errors of clinical target volumes and their impact on dose accumulation for head and neck radiotherapy.
    Radiother Oncol. 2023;188:109856.
    PubMed         Abstract available

  98. KOTEVSKI DP, Vajdic CM, Field M, Smee RI, et al
    Inter-hospital variation in data collection, radiotherapy treatment, and survival in patients with head and neck cancer: A multisite study.
    Radiother Oncol. 2023;188:109843.
    PubMed         Abstract available

  99. LARROTTA-CASTILLO D, Chen YH, van der Hoek L, Ramaekers B, et al
    Post-radiotherapy health utility and symptom trends in patients with non-metastatic head and neck cancer.
    Radiother Oncol. 2026 Mar 9:111473. doi: 10.1016/j.radonc.2026.111473.
    PubMed         Abstract available

  100. ADRIAN G, Falklind NR, McDowell L, Gebre-Medhin M, et al
    Six versus five fractions per week (Chemo)-Radiotherapy for locally advanced head and neck squamous cell carcinoma - A nationwide cohort study from the swedish head and neck cancer register.
    Radiother Oncol. 2026 Mar 7:111481. doi: 10.1016/j.radonc.2026.111481.
    PubMed         Abstract available

  101. GONG J, Yang Z, Li J, Wang Q, et al
    A longitudinal CT-based subregional radiomics nomogram for predicting local recurrence-free survival in esophageal squamous cell carcinoma after definitive chemoradiotherapy: a multicenter study.
    Radiother Oncol. 2026;218:111471.
    PubMed         Abstract available


    Thyroid

  102. PATHAK KA, Agarwal A, Klemm N, Kotecha P, et al
    Selective Use of Radioiodine Therapy in Differentiated Thyroid Carcinoma: A Population-Based Cohort Study.
    Thyroid. 2026;36:345-349.
    PubMed         Abstract available

  103. CHEN M, Jiang K, Zhang Q, Xiao X, et al
    DDX21 Links BRAF(V600E) and TERT to Promote Thyroid Cancer Progression.
    Thyroid. 2026;36:305-319.
    PubMed         Abstract available

  104. YIELDER R, Bolland M, Petrie KJ
    Precautionary Behaviors and Side Effects after Radioiodine for Thyroid Disease: A Prospective Cohort Study.
    Thyroid. 2026;36:203-212.
    PubMed         Abstract available

  105. LIM H, Cho SJ, Baek JH
    Active Surveillance for Locoregional Recurrent Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis.
    Thyroid. 2026;36:121-132.
    PubMed         Abstract available

  106. BEIRIGER J, Estephan LE, Campbell D, Dhillon VK, et al
    Evaluating Artificial Intelligence Chatbots for Patient Education on Thyroid Radiofrequency Ablation: An Analysis of Accuracy, Quality, and Readability.
    Thyroid. 2026;36:162-168.
    PubMed         Abstract available

  107. THOMAS J, Tessler FN
    Artificial Intelligence Applications in Thyroid Cancer Diagnosis: 2026 Update.
    Thyroid. 2026;36:133-140.
    PubMed         Abstract available

  108. HAMIDI S, Vodopivec DM, Busaidy NL, Gule-Monroe M, et al
    Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic BRAF Wild-Type Anaplastic Thyroid Carcinoma.
    Thyroid. 2026;36:153-161.
    PubMed         Abstract available

  109. CUNNINGHAM CE, van Dijk S, Langer MM, Moronta S, et al
    A Thyroid-Cancer-Specific Utility Index: Development and Valuation of the Thyroid Cancer Quality of Life Index.
    Thyroid. 2026 Feb 24:10507256261425624. doi: 10.1177/10507256261425624.
    PubMed         Abstract available

  110. AHN SH, Seo SH, Jung CY, Yu DH, et al
    Long-Term Morbidity after Postoperative Hypoparathyroidism in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study.
    Thyroid. 2026 Feb 18:10507256261425690. doi: 10.1177/10507256261425690.
    PubMed         Abstract available

  111. ROJAS T, Solis-Pazmino P, Figueroa LA, Ledesma TM, et al
    Pre-Radioiodine Thyrotropin Thresholds During Withdrawal Preparation in Differentiated Thyroid Cancer after Total Thyroidectomy: A Systematic Review and Meta-Analysis.
    Thyroid. 2026 Feb 11:10507256261423206. doi: 10.1177/10507256261423206.
    PubMed         Abstract available

  112. GRASSI ES, Ghiandai V, Gaudenzi G, Massardi E, et al
    Patient-Derived in Vitro Models Reveal Insights into Medullary Thyroid Cancer Microenvironment and Resistance to Tyrosine Kinase Inhibitors.
    Thyroid. 2026 Feb 6:10507256251408825. doi: 10.1177/10507256251408825.
    PubMed         Abstract available

  113. MACHLAH YM, Brandenburg T, Hones GS, Theurer S, et al
    ALK Inhibition Prolongs Survival in a Mouse Model of ALK-Positive Anaplastic Thyroid Cancer.
    Thyroid. 2025 Dec 18. doi: 10.1177/10507256251409070.
    PubMed         Abstract available

  114. HUSTON-PATERSON HH, Mao Y, Kim J, Tseng CH, et al
    Disparities in Initial Thyroid Cancer Care by Hospital Treatment Volume: Analysis of 52,599 Cases in California.
    Thyroid. 2023 Jul 27. doi: 10.1089/thy.2023.0241.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum